TipRanks
Puig Brands, S.A. (MX:PUIGN)
:PUIGN
Mexico Market
EarningsQ4 2025 Earnings Report

Puig Brands, S.A. (PUIGN) Q4 2025 Earnings Report

0 Followers

MX:PUIGN Q4 2025 EPS Results

Actual EPS$13.18
Consensus EPS$12.00
Beat/MissBeat by +$1.18
One Year Ago EPS$12.50

MX:PUIGN Q4 2025 Revenue Results

Actual Revenue$53.97B
Expected Revenue$27.63B
Beat/MissBeat by +$26.34B
YoY Revenue Growth+4.74%

Earnings Announcement Details

QuarterQ4 2025
Date02/18/2026
TimeBefore Open
Conference CallWednesday, February 18, 2026
MX:PUIGN Upcoming Earnings
Puig Brands, S.A.'s next earnings date is estimated for March 4, 2027, based on past reporting schedules.

Q4 2025 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q4 2025 Earnings Slide Deck

No slide deck is available for this earnings event.

Q4 2025 Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 18, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed a predominately positive operational and financial story: record revenues above EUR 5 billion, margin expansion, strong adjusted EBITDA and cash generation, standout performance in makeup and Asia Pacific, and a strengthened balance sheet. However, management was transparent about notable near‑term headwinds (foreign exchange, tariffs, Argentina hyperinflation), some margin pressure in specific segments (Fragrance & Fashion and Skincare), and associate/brand‑specific challenges. On balance, the positive execution, broad‑based growth, improved profitability and balance sheet flexibility outweigh the headwinds, though FX and select integration/investment costs remain items to monitor for 2026.
Company Guidance
Puig’s 2026 guidance framework signals continued like‑for‑like outperformance versus the premium beauty market (no firm revenue target), while flagging a notable FX headwind (Q4‑2025 FX −3.6% and a similar ~3.6% drag expected in Q1 2026) and a tough Q1 fragrance comp; adjusted EBITDA margins are expected to remain broadly stable around the 20.7% level achieved in 2025 (management had previously flagged ~+20 bps potential), with medium‑term upside from mix and operational discipline despite tariffs and FX, and continued healthy brand investment. Capital and cash priorities are unchanged: target net debt/adjusted EBITDA ≤2x (year‑end leverage 0.7x; net debt €716m), a 40% dividend payout policy (2025 dividend proposed ≈€237m or €0.42/share subject to AGM), selective M&A, and planned cash outflows including €351m of minority‑stake maturities in H1‑2026; 2025 free cash‑flow conversion was 64% and CapEx ran at ~4% of sales.
Record Revenue and Top‑End Like‑for‑Like Growth
Net revenues surpassed EUR 5.0 billion for FY2025, representing +7.8% like‑for‑like growth and +5.3% reported growth — at the top end of guidance (6%–8% LFL). Q4 net revenues reached EUR 1.45 billion with 9.8% like‑for‑like growth.
Strong Profitability and Cash Generation
Gross profit margin improved to 75.1% (up ~19 bps vs. 2024). Adjusted EBITDA was EUR 1.045 billion with a margin of 20.7% (+49 bps vs. 2024). Adjusted net profit was EUR 587 million (+6.5% YoY) and free cash flow conversion was 64% of adjusted EBITDA.
Makeup Segment Outperformance (Charlotte Tilbury-led)
Makeup revenues reached EUR 845 million, up +13.7% like‑for‑like (Q4 like‑for‑like +26.5%). Charlotte Tilbury delivered exceptional performance, expanded distribution (Amazon U.S., new market Mexico), and retained strong ranking (#1 UK prestige makeup, #3 U.S.).
High Growth in Asia Pacific
Asia Pacific was the fastest‑growing region with EUR 530 million in sales and +21.7% like‑for‑like growth for FY2025 (Q4 +18.9% LFL), driven by Charlotte Tilbury, Niche and Derma brands (noting some benefit from consolidation effects not expected to repeat).
Fragrance & Fashion Resilience and Market Position
Fragrance & Fashion (72% of group revenues) delivered EUR 3.6 billion and +6.4% like‑for‑like growth. Puig defended global value market share at 11.1% and saw double‑digit outperformance from its Niche portfolio (Byredo) and strong performances from Carolina Herrera and Jean Paul Gaultier.
Skincare Delivered Consistent Growth
Skincare revenues were EUR 551 million, up +8.9% like‑for‑like (Q4 EUR 141 million, +7.9% LFL). Growth led by Uriage (double‑digit) and supported by Charlotte Tilbury skincare and new product launches.
Improved Balance Sheet and Capital Allocation
Net debt reduced to EUR 716 million (leverage 0.7x net debt/adjusted EBITDA, ~0.4x improvement YoY). Operational cash flow improved to EUR 684 million; CapEx ~4% of net revenues. Board proposed a 40% payout ratio translating to EUR 237 million dividend (EUR 0.42/share, subject to AGM).
Operational Progress and Strategic Momentum
Completed previous 5‑year strategic plan (more than tripled 2020 revenue by 2025). Ongoing operational initiatives include transition of Chartres production plant (move to new site by H1 2027) and a planned Capital Markets Day on April 14, 2026 to present the next roadmap.

MX:PUIGN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Mar 04, 2027
2026 (Q4)
12.59 / -
13.185
Jul 30, 2026
2026 (Q2)
8.76 / 9.05
8.6594.55% (+0.39)
2025 (Q4)
12.00 / 13.18
12.4965.51% (+0.69)
2025 (Q2)
9.05 / 8.66
8.6590.00% (0.00)
Feb 27, 2025
2024 (Q4)
10.37 / 12.50
Sep 06, 2024
2024 (Q2)
- / 8.66
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed